首页> 美国卫生研究院文献>Contemporary Oncology >The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an initially unresectable disease

【2h】

The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an initially unresectable disease

机译：术前改良的格拉斯哥预后评分用于预测非手术治疗最初无法切除的疾病后胰腺癌切除术后的存活率

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim of the studyRecent advances in chemotherapy have increasingly enabled conversion surgery (CS) in patients with initially unresectable pancreatic cancer (PC), but patient selection remains controversial. We examined the characteristics of patients who would benefit from this procedure.

机译：研究的目的化学疗法的最新进展越来越多地使最初无法手术切除的胰腺癌（PC）的患者能够进行转化手术（CS），但是患者的选择仍然存在争议。我们检查了将从该程序中受益的患者的特征。

著录项

期刊名称 Contemporary Oncology
作者
Shinichi Ikuta; Takashi Sonoda; Tsukasa Aihara; Takayoshi Nakajima; Naoki Yamanaka;
展开▼
作者单位

展开▼
年(卷),期 2018(22),4
年度 2018
页码 229–235
总页数 7
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
pancreatic cancer conversion surgery modified Glasgow prognostic score;

机译：胰腺癌;转换手术;改良的格拉斯哥预后评分;

相似文献

外文文献
中文文献
专利

1. Response to the Comment on "'Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer': What Is Good for the Surgeon Is Just as Good for the Patient?'' The Case of Unresectable Pancreatic Cancer After Neoadjuvant Treatment [J] . Annals of Surgery . 2020,第4期

机译：回应关于新辅助治疗后生存率的预后因素对初始不可切除的胰腺癌的预后因素'：对外科医生的好处对患者同样好吗？“新辅助治疗后不可切除的胰腺癌的情况
2. Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer'': What Is Good for the Surgeon Is Just as Good for the Patient? [J] . Annals of Surgery . 2020,第4期

机译：评论“新辅助治疗后生存率的预后因素，初始不可切除的胰腺癌患者”：对外科医生有益的是对患者的好处？
3. Response to the Comment on "Prognostic Factors of Survival After Neoadjuvant Treatment and Resection for Initially Unresectable Pancreatic Cancer'' [J] . Annals of Surgery . 2020,第4期

机译：回应关于“新辅助治疗后生存率的预后因素及初始不可切除的胰腺癌的生存因子”评论
4. DeepPrognosis: Preoperative Prediction of Pancreatic Cancer Survival and Surgical Margin via Contrast-Enhanced CT Imaging [C] . Jiawen Yao, Yu Shi, Le Lu, International Conference on Medical Image Computing and Computer-Assisted Intervention . 2020

机译：深度突出：通过对比增强CT成像对胰腺癌存活和手术边缘的术前预测
5. Preclinical evaluation of inhibitors of the phosphatidylinositide 3-kinase/protein kinase B cell survival pathway in the treatment of pancreatic cancer. [D] . Ng, Sylvia Sze Wai. 2002

机译：磷脂酰肌醇3激酶/蛋白激酶B细胞存活途径抑制剂在胰腺癌治疗中的临床前评价。
6. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score [O] . Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, 2020

机译：Glasgow预后评分是胃癌患者长期存活的更好预测因素而改良的Glasgow预后评分或高敏感性改性Glasgow预后得分相比
7. Table 5.5.a.1 Tumor size and treatment (rate of resectability) Figure 5.5.a.2 Cumulative survival of the patients after pancreatectomy for TS1 cancer according to residual tumors Figure 5.5.a.3 Cumulative survival of the patients with TS1 cancer according to extent of lymph node dissection Figure 5.5.a.4 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.5 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.6 Combined resection of peripancreatic plexus when there is no plexus infiltration and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.7 Combined resection of artery and cumulative survival of the patients after pancreatectomy for TS1 cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.8 Combined resection of portal vein and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head Figure 5.5.a.9 Combined resection of peripancreatic plexus and cumulative survival of the patients after pancreatectomy for TS2 (2.1-4.0 cm) cancer of UICC Stage IIa or IIb in the pancreatic head [O] . 2007

机译：表5.5.a.1肿瘤大小和治疗（重新切性率）图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度，TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后，患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时，围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后，患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头

The preoperative modified Glasgow prognostic score for the prediction of survival after pancreatic cancer resection following non-surgical treatment of an initially unresectable disease

摘要

著录项

相似文献

相关主题

期刊订阅